The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine
- PMID: 20422403
- PMCID: PMC2885299
- DOI: 10.1007/s00213-010-1868-x
The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine
Abstract
Rationale: Previous studies have shown that blockade of metabotropic glutamate 5 receptors (mGluR5) results in inhibition of nicotine self-administration in experimental animals. However, these studies have not established the behavioural mechanisms which mediate these effects or the extent to which the effects of mGluR5 antagonism on nicotine self-administration reflect a selective attenuation of nicotine reinforcement.
Objectives: To investigate the effects of antagonising mGluR5 receptors on psychopharmacological responses to nicotine measured using conditioned and unconditioned behaviours.
Results: 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) significantly (P < 0.01) reduced nicotine self-administration and attenuated (P < 0.01) the ability of non-contingent nicotine to enhance the reinforcing properties of a weak reinforcer (extinguishing the house light in an operant chamber). It also attenuated (P < 0.05) the much lower levels of responding for this reinforcer measured in control animals treated with saline. MPEP did not attenuate the increase in locomotor activity induced by acute and repeated nicotine in animals habituated on the test day to the test environment. Furthermore, it had no significant effects on responding for a palatable food reward. By contrast, MPEP significantly reduced (P < 0.001) conditioned locomotor stimulation evoked by pairing nicotine with a specific environment.
Conclusion: The results are consistent with the hypothesis that mGluR5 receptors play an important role in mediating the effects of contextual cues in conditioned behavioural responses to nicotine.
Figures







Similar articles
-
Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats.Neuropharmacology. 2011 Dec;61(8):1399-405. doi: 10.1016/j.neuropharm.2011.08.028. Epub 2011 Aug 31. Neuropharmacology. 2011. PMID: 21896278 Free PMC article.
-
Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.Neuropharmacology. 2005;49 Suppl 1:167-78. doi: 10.1016/j.neuropharm.2005.06.007. Neuropharmacology. 2005. PMID: 16023685
-
The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.Psychopharmacology (Berl). 2003 May;167(3):257-64. doi: 10.1007/s00213-003-1432-z. Epub 2003 Apr 8. Psychopharmacology (Berl). 2003. PMID: 12682710
-
Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine.Neuropsychopharmacology. 2008 Aug;33(9):2139-47. doi: 10.1038/sj.npp.1301623. Epub 2007 Nov 28. Neuropsychopharmacology. 2008. PMID: 18046312 Free PMC article.
-
The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain.Behav Brain Res. 2011 Jun 1;219(2):354-7. doi: 10.1016/j.bbr.2010.12.024. Epub 2011 Jan 7. Behav Brain Res. 2011. PMID: 21216262
Cited by
-
Nicotine Use and Metabotropic Glutamate Receptor 5 in Individuals With Major Depressive and Posttraumatic Stress Disorders.Chronic Stress (Thousand Oaks). 2023 Feb 9;7:24705470231154842. doi: 10.1177/24705470231154842. eCollection 2023 Jan-Dec. Chronic Stress (Thousand Oaks). 2023. PMID: 36843572 Free PMC article.
-
N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.Bioorg Med Chem Lett. 2016 Apr 15;26(8):1894-900. doi: 10.1016/j.bmcl.2016.03.026. Epub 2016 Mar 9. Bioorg Med Chem Lett. 2016. PMID: 26988308 Free PMC article.
-
The "stop" and "go" of nicotine dependence: role of GABA and glutamate.Cold Spring Harb Perspect Med. 2013 Jun 1;3(6):a012146. doi: 10.1101/cshperspect.a012146. Cold Spring Harb Perspect Med. 2013. PMID: 23732855 Free PMC article. Review.
-
New medications development for smoking cessation.Addict Neurosci. 2023 Sep;7:100103. doi: 10.1016/j.addicn.2023.100103. Epub 2023 May 18. Addict Neurosci. 2023. PMID: 37519910 Free PMC article.
-
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.Bioorg Med Chem Lett. 2013 Nov 1;23(21):5779-85. doi: 10.1016/j.bmcl.2013.09.001. Epub 2013 Sep 10. Bioorg Med Chem Lett. 2013. PMID: 24074843 Free PMC article.
References
-
- Arroyo M, Markou A, Robbins TW, Everitt BJ. Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine. Psychopharmacology. 1998;140:331–344. doi: 10.1007/s002130050774. - DOI - PubMed
-
- Balfour DJ. Complementary roles for the accumbal shell and core in nicotine dependence. In: Bock G, Goode J, editors. Understanding nicotine and tobacco addiction (Novartis Symposium 272) Chichester: Wiley; 2006. pp. 96–115.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources